microdosing schedule for tirzepatide + Glycine Product Guide Compounded Tirzepatide Microdoses - Weight

[DOI] [PubMed] [Google Scholar] 105.Matulonis UA, Horowitz NS, Campos SM, et al

Discuss switching to tirzepatide, which shows better average weight loss than semaglutide

Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in patients with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity, and since 2024 for cardiovascular risk reduction in patients with established cardiovascular disease and overweight or obesity

Whether you're considering semaglutide or just starting your journey, her candid story reveals what doctors might not tell you about life on a GLP-1

doi: 10.1093/rheumatology/kez302